breast cancer Clinical Trials and Research
Also known as: bc, mammary cancer, ductal carcinoma, lobular carcinoma, breast neoplasm, cancer of the breast · ICD-10: C50
Breast cancer is a disease where cells in the breast grow out of control. Clinical trial research focuses on developing new therapies, improving early detection, and understanding prevention to enhance patient outcomes. Find a Trial helps patients and caregivers search for active studies exploring these advancements.
Common questions about breast cancer clinical trials
Who can participate in breast cancer clinical trials?
Eligibility criteria vary by study, often including factors like cancer stage, previous treatments, and overall health. Researchers use these criteria to ensure patient safety and study relevance. Information on specific criteria for individual trials is available on ClinicalTrials.gov.
What are the different phases of breast cancer clinical trials?
Clinical trials progress through phases (1, 2, 3, and 4) to test safety and effectiveness. Phase 1 studies assess safety, Phase 2 evaluates efficacy, and Phase 3 compares new treatments to standard ones. Data from ClinicalTrials.gov outlines these phases and their objectives.
Do breast cancer clinical trials cost money to participate in?
Generally, study-related medical costs for clinical trial participation are covered by the trial sponsor. However, routine medical care costs, like standard doctor visits, may still be billed to insurance. Patients should always clarify financial details with the research team before enrolling.
What new treatments are being studied for breast cancer?
Current research, as seen on ClinicalTrials.gov and NIH RePORTER, explores targeted therapies, immunotherapies, and novel chemotherapy combinations. Studies also investigate new surgical techniques and radiation approaches to improve outcomes and reduce side effects for various breast cancer types.
What types of interventions are common in breast cancer trials?
Interventions often include new drugs, different radiation schedules, surgical techniques, or behavioral changes. Trials might also compare existing treatments to find the most effective options for specific breast cancer types. This data is publicly available on ClinicalTrials.gov.
What biomarkers are important in breast cancer research?
Key biomarkers include hormone receptors (estrogen receptor, progesterone receptor) and HER2 status, which guide targeted therapies. Researchers are also studying new genetic markers to predict treatment response and identify patients for specific trials, as shown on NIH RePORTER.
What might prevent someone from joining a breast cancer trial?
Common exclusion criteria can include certain pre-existing medical conditions, specific prior treatments, or pregnancy. These criteria help ensure patient safety and the integrity of the study results. Each trial lists its specific requirements on platforms like ClinicalTrials.gov.
Are there clinical trials focused on breast cancer prevention or screening?
Yes, many trials investigate new methods for breast cancer prevention, such as lifestyle interventions or preventive medications. Others focus on improving screening techniques, like advanced imaging or blood tests, to detect cancer earlier. Information is available on ClinicalTrials.gov and NIH RePORTER.
How to find a breast cancer trial that fits you
- Describe your breast cancer situation in detail — stage if applicable, prior treatments, age, and other relevant conditions.
- Use the location filter (worldwide, US, US & Canada, Europe) to narrow to trials near you.
- Review each trial's eligibility criteria carefully. Save 2–5 candidates with their NCT numbers.
- Discuss with your treating clinician before contacting the research site.
Browse all breast cancer trials →